University of Oxford
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1096-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ox.ac.uk
Controlled Human Malaria Infection in Semi-Immune Kenyan Adults. (CHMI-SIKA)
- Conditions
- Malaria
- Interventions
- Biological: Plasmodium falciparum sporozoite (PfSPZ)
- First Posted Date
- 2016-04-15
- Last Posted Date
- 2016-05-30
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 200
- Registration Number
- NCT02739763
- Locations
- 🇰🇪
KEMRI Centre for Clinical Research, Nairobi, Kenya
🇰🇪KEMRI Wellcome Trust Research Programme, Kilifi, Coast, Kenya
Adaptation Time Required for the Optimisation of Maia Microperimetry Visual Field Testing
- Conditions
- Retina; Change
- First Posted Date
- 2016-04-06
- Last Posted Date
- 2018-11-08
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 40
- Registration Number
- NCT02729818
- Locations
- 🇬🇧
Nuffield Laboratory of Ophthalmology, Oxford, United Kingdom
NUC-3373 in Advanced Solid Tumours
- Conditions
- Cancer
- Interventions
- Drug: NUC-3373
- First Posted Date
- 2016-03-30
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 62
- Registration Number
- NCT02723240
- Locations
- 🇬🇧
Belfast City Hospital, Belfast, United Kingdom
🇬🇧Oxford University Hospitals NHS Trust, Oxford, United Kingdom
🇬🇧Beatson, West of Scotland Cancer Centre, Glasgow, United Kingdom
Trial of Exercise to Prevent HypeRtension in Young Adults
- Conditions
- Premature BirthHypertension
- Interventions
- Behavioral: Aerobic Exercise
- First Posted Date
- 2016-03-30
- Last Posted Date
- 2021-02-02
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 203
- Registration Number
- NCT02723552
- Locations
- 🇬🇧
Cardiovascular Clinical Research Facility, Dept of Cardiovascular Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom
Defining the Physiological Mechanisms of Risk Genes for Hyperglycaemia, Insulin Resistance and Type 2 Diabetes
- Conditions
- Type 2 Diabetes
- Interventions
- Other: 4 Hour Frequently Sampled Oral Glucose Tolerance TestOther: Isoglycaemic Clamp
- First Posted Date
- 2016-03-30
- Last Posted Date
- 2016-06-22
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 40
- Registration Number
- NCT02723110
- Locations
- 🇬🇧
OCDEM, University of Oxford, Oxford, Oxfordshire, United Kingdom
Safety and Efficacy of the Alpha AMS Subretinal Implant
- Conditions
- Retinitis Pigmentosa
- Interventions
- Device: Implant 'on' vs implant 'off'
- First Posted Date
- 2016-03-28
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 6
- Registration Number
- NCT02720640
- Locations
- 🇬🇧
Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom
Aerosol BCG Challenge Trial in Healthy UK Adults
- Conditions
- Tuberculosis
- Interventions
- Biological: BCGOther: Saline placebo
- First Posted Date
- 2016-03-16
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 46
- Registration Number
- NCT02709278
- Locations
- 🇬🇧
NIHR Wellcome Trust Clinical Research Facility, University of Birmingham, Birmingham, West Midlands, United Kingdom
🇬🇧Oxford University Hospitals- John Warin Ward, University of Oxford, Oxford, Oxfordshire, United Kingdom
🇬🇧Centre for Clinical Vaccinology and Tropical Medicine , University of Oxford, Oxford, Oxfordshire, United Kingdom
RSA-measured in Vivo Migration and Micromotion in the DePuy Tri-Lock, Corail and Deltamotion Hip Replacement Components
- Conditions
- Hip Osteoarthritis
- Interventions
- Device: DePuy Corail® femoral stem + Deltamotion® acetabular componentDevice: DePuy Tri-Lock® femoral stem + Deltamotion® acetabular component
- First Posted Date
- 2016-03-02
- Last Posted Date
- 2016-03-02
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 40
- Registration Number
- NCT02696395
- Locations
- 🇬🇧
Nuffield Orthopaedic Centre, Oxford, United Kingdom
SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitis
- Conditions
- Non-alcoholic Fatty Liver Disease
- Interventions
- Drug: SGLT2 inhibitorDrug: Metformin
- First Posted Date
- 2016-03-02
- Last Posted Date
- 2018-05-04
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 20
- Registration Number
- NCT02696941
- Locations
- 🇬🇧
University of Oxford, Oxford, United Kingdom
Study of Artemether-lumefantrine, Amodiaquine and Primaquine in Healthy Subjects
- Conditions
- Drug CombinationHealthyPharmacokinetic
- Interventions
- First Posted Date
- 2016-03-02
- Last Posted Date
- 2019-06-28
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 17
- Registration Number
- NCT02696954
- Locations
- 🇹🇭
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand